This Founder’s Gene Therapy Company Helped Blind Kids See Again [Forbes]
MeiraGTx Holdings plc - Ordinary Shares (MGTX)
Company Research
Source: Forbes
MeiraGTx founder & CEO Zandy Forbes Omar Saval / MeiraGTx E ach year hundreds of children are born legally blind because of a genetic disorder that degrades their retinas. Though some can distinguish between light and dark early on, a defect in their AIPL1 gene leaves most without sight by the time they turn four. The disorder has long been considered irreversible. But that's no longer true. A new gene therapy from publicly traded company MeiraGTx has managed to do something unprecedented: It's given eyesight to 11 children who were born blind. Surgeons at Moorsfield Eye Hospital and University College London injected the retinas of kids born with the AIPL1 defect with an MeiraGTx therapy that introduces a correct version of the gene, which causes their bodies to produce the mechanisms that enable sight. Within weeks they were able to see for the first time. Now, years later they all are capable of reading, coloring and playing like other children with the aid of glasses.
Show less
Read more
Impact Snapshot
Event Time:
MGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTX alerts
High impacting MeiraGTx Holdings plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MGTX
News
- MeiraGTx (NASDAQ:MGTX) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.MarketBeat
- MeiraGTx (NASDAQ:MGTX) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.MarketBeat
- Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx ConferencePR Newswire
- MeiraGTx (NASDAQ:MGTX) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
- MeiraGTx Reports Third Quarter 2025 Financial and Operational ResultsGlobeNewswire
MGTX
Earnings
- 11/13/25 - Miss
MGTX
Sec Filings
- 12/23/25 - Form 4
- 11/24/25 - Form 4
- 11/13/25 - Form SCHEDULE
- MGTX's page on the SEC website